Clinical trial
Comparison of the Diagnostic Potential of Colonoscopy, and Artificial Intelligence-assisted Fecal Microbiome Testing for Colon Cancer
NCT05795725 is registered in ClinicalTrials.gov with Istanbul Medipol University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Diagnostic Potential of Colonoscopy, and Artificial Intelligence-assisted Fecal Microbiome Testing for Colon Cancer
- Lead sponsor
- Istanbul Medipol University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2023
- Completion date
- May 31, 2024
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer, colonoscopy, microbiota